Danka Radosavljevic
Fortuna: 1 M $ al 31/08/2026
Fortuna: 1 M $ al 31/08/2026
Danka Radosavljevic is currently Chief Operating Officer at Eton Pharmaceuticals, Inc. Formerly, Mr. Radosavljevic worked as a Project Manager at Akorn, Inc. and as a Quality Control & Analytical Development Scientist at Morton Grove Pharmaceuticals, Inc. Mr. Radosavljevic completed undergraduate studies at the University of Illinois.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/07/2026 | 22.473 ( 0,08 % ) | 1 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ETON PHARMACEUTICALS, INC. | Director de Operaciones | - |
| Empresas | Cargo | Fin |
|---|---|---|
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Corporate Officer/Principal | - |
| AKORN, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Akorn, Inc.
Akorn, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes therapeutic, diagnostic & surgical pharmaceuticals | Health Technology |
Morton Grove Pharmaceuticals, Inc.
Morton Grove Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets liquid pharmaceutical products | Health Technology |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes prescription drug products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.